NO952130D0 - Anvendelse av tieno(1,5)benzodiazepin for behandling av tilstander i mave/tarmkanalen - Google Patents
Anvendelse av tieno(1,5)benzodiazepin for behandling av tilstander i mave/tarmkanalenInfo
- Publication number
- NO952130D0 NO952130D0 NO952130A NO952130A NO952130D0 NO 952130 D0 NO952130 D0 NO 952130D0 NO 952130 A NO952130 A NO 952130A NO 952130 A NO952130 A NO 952130A NO 952130 D0 NO952130 D0 NO 952130D0
- Authority
- NO
- Norway
- Prior art keywords
- benzodiazepine
- thieno
- treatment
- gastrointestinal conditions
- gastrointestinal
- Prior art date
Links
- ZVAPWJGRRUHKGP-UHFFFAOYSA-N 1h-1,5-benzodiazepine Chemical compound N1C=CC=NC2=CC=CC=C12 ZVAPWJGRRUHKGP-UHFFFAOYSA-N 0.000 title 1
- 206010017943 Gastrointestinal conditions Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/253,658 US5457101A (en) | 1994-06-03 | 1994-06-03 | Thieno[1,5]benzoidiazepine use |
Publications (3)
Publication Number | Publication Date |
---|---|
NO952130D0 true NO952130D0 (no) | 1995-05-30 |
NO952130L NO952130L (no) | 1995-12-04 |
NO306977B1 NO306977B1 (no) | 2000-01-24 |
Family
ID=22961179
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO952130A NO306977B1 (no) | 1994-06-03 | 1995-05-30 | Anvendelse av tienol[1,5]benzodiazepin for behandling av tilstander i mave/tarmkanalen |
Country Status (14)
Country | Link |
---|---|
US (1) | US5457101A (no) |
EP (1) | EP0685233B1 (no) |
JP (1) | JPH07330608A (no) |
KR (1) | KR960000229A (no) |
CN (1) | CN1119101A (no) |
AU (1) | AU684924B2 (no) |
CA (1) | CA2150517A1 (no) |
DE (1) | DE69528109D1 (no) |
HU (1) | HUT71598A (no) |
IL (1) | IL113912A (no) |
NO (1) | NO306977B1 (no) |
NZ (1) | NZ272231A (no) |
TW (1) | TW372872B (no) |
ZA (1) | ZA954358B (no) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EG23659A (en) * | 1995-03-24 | 2007-03-26 | Lilly Co Eli | Process and crystal forms of methyl-thieno-benzodiazepine |
EG24221A (en) * | 1995-03-24 | 2008-11-10 | Lilly Co Eli | Process for preparing olanzapine |
US5637584A (en) * | 1995-03-24 | 1997-06-10 | Eli Lilly And Company | Solvate of olanzapine |
CR5278A (es) | 1995-03-24 | 1996-07-04 | Lilly Co Eli | Formulacion oral de 2-metil-tieno-benzodiacepina |
US5631250A (en) * | 1995-03-24 | 1997-05-20 | Eli Lilly And Company | Process and solvate of 2-methyl-thieno-benzodiazepine |
US5891461A (en) * | 1995-09-14 | 1999-04-06 | Cygnus, Inc. | Transdermal administration of olanzapine |
US5981523A (en) * | 1996-02-05 | 1999-11-09 | Eli Lilly And Company | Compounds and methods for treating multiple sclerosis |
BR9612552A (pt) * | 1996-03-11 | 1999-07-20 | Lilly Co Eli | Processo para tratamento de autismo |
CN1213966A (zh) * | 1996-03-11 | 1999-04-14 | 伊莱利利公司 | 治疗两极紊乱的方法 |
PL329221A1 (en) * | 1996-03-25 | 1999-03-15 | Lilly Co Eli | Method of relieving hemicrania pains |
AU721338B2 (en) * | 1996-03-25 | 2000-06-29 | Eli Lilly And Company | Method for treating pain |
AU725556B2 (en) * | 1996-03-25 | 2000-10-12 | Eli Lilly And Company | Method for treating pain |
US5958934A (en) * | 1996-05-23 | 1999-09-28 | Syntex (U.S.A.) Inc. | Aryl pyrimidine derivatives and uses thereof |
US5952331A (en) * | 1996-05-23 | 1999-09-14 | Syntex (Usa) Inc. | Aryl pyrimidine derivatives |
WO1998046596A1 (en) * | 1997-04-15 | 1998-10-22 | Eli Lilly And Company | Method for providing neuro-protective effects |
US20030022889A1 (en) * | 1997-04-15 | 2003-01-30 | Bymaster Franklin P. | Method for providing neuro-protective effects |
JP2002530339A (ja) | 1998-11-23 | 2002-09-17 | セプラコール, インク. | 2−ヒドロキシメチルオランザピン組成物及び方法 |
ATE253364T1 (de) * | 1998-11-23 | 2003-11-15 | Sepracor Inc | Olanzapin-n-oxide enthaltende pharmaceutische zusammensetzungen |
JP2002530341A (ja) * | 1998-11-23 | 2002-09-17 | セプラコール, インク. | デスメチルオランザピン組成物及び方法 |
US7022698B2 (en) | 1999-12-28 | 2006-04-04 | U & I Pharmaceuticals, Ltd. | Pharmaceutical compositions containing new polymorphic forms of olanzapine and uses thereof |
US6348458B1 (en) | 1999-12-28 | 2002-02-19 | U & I Pharmaceuticals Ltd. | Polymorphic forms of olanzapine |
US7458374B2 (en) | 2002-05-13 | 2008-12-02 | Alexza Pharmaceuticals, Inc. | Method and apparatus for vaporizing a compound |
US20030051728A1 (en) | 2001-06-05 | 2003-03-20 | Lloyd Peter M. | Method and device for delivering a physiologically active compound |
US7645442B2 (en) | 2001-05-24 | 2010-01-12 | Alexza Pharmaceuticals, Inc. | Rapid-heating drug delivery article and method of use |
US20070122353A1 (en) | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
UA80095C2 (en) * | 2001-07-20 | 2007-08-27 | Lilly Co Eli | 2 methyl-thieno-benzodiazepine lyophilized formulation and method for the preparation thereof |
GB0203061D0 (en) * | 2002-02-08 | 2002-03-27 | Novartis Ag | Organic compounds |
GB0207091D0 (en) * | 2002-03-26 | 2002-05-08 | Ml Lab Plc | Method of treatment |
US7407788B2 (en) * | 2002-11-21 | 2008-08-05 | Danisco A/S, Genencor Division | BGL7 beta-glucosidase and nucleic acids encoding the same |
US20040105818A1 (en) | 2002-11-26 | 2004-06-03 | Alexza Molecular Delivery Corporation | Diuretic aerosols and methods of making and using them |
US7913688B2 (en) | 2002-11-27 | 2011-03-29 | Alexza Pharmaceuticals, Inc. | Inhalation device for producing a drug aerosol |
WO2004104490A1 (en) | 2003-05-21 | 2004-12-02 | Alexza Pharmaceuticals, Inc. | Self-contained heating unit and drug-supply unit employing same |
GB0314149D0 (en) * | 2003-06-18 | 2003-07-23 | Generics Uk Ltd | Novel amorphous forms |
US20050272720A1 (en) * | 2004-01-27 | 2005-12-08 | Rolf Keltjens | Process for making olanzapine Form I |
DE602005027308D1 (de) * | 2004-01-27 | 2011-05-19 | Synthon Bv | Stabile salze von olanzapin |
US7540286B2 (en) | 2004-06-03 | 2009-06-02 | Alexza Pharmaceuticals, Inc. | Multiple dose condensation aerosol devices and methods of forming condensation aerosols |
CA2597716A1 (en) * | 2005-02-15 | 2006-08-24 | Elan Pharma International Limited | Aerosol and injectable formulations of nanoparticulate benzodiazepine |
WO2007020080A1 (en) * | 2005-08-17 | 2007-02-22 | Synthon B.V. | A process for making olanzapine form i |
US20070293479A1 (en) * | 2006-05-18 | 2007-12-20 | Osinga Niels J | Olanzapine pharmaceutical composition |
CL2007002807A1 (es) * | 2006-09-29 | 2008-04-11 | Synthon Bv | Composicion farmaceutica en estado solido que comprende olanzapina o una sal farmaceuticamente aceptable de la misma y lactosa anhidra; tableta farmaceutica oral; procedimiento de preparacion de dicha tableta, util en el tratamiento de la esquizofren |
ES2594867T3 (es) | 2007-03-09 | 2016-12-23 | Alexza Pharmaceuticals, Inc. | Unidad de calentamiento para usar en un dispositivo de administración de fármaco |
WO2012051502A1 (en) | 2010-10-14 | 2012-04-19 | University Of Utah Research Foundation | Methods and compositions related to neuroactive thiazoline compounds |
US20210355138A1 (en) * | 2016-08-11 | 2021-11-18 | Eli Lilly And Company | Aminothiazinies and their use as bace1 inhibitors |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5229382A (en) * | 1990-04-25 | 1993-07-20 | Lilly Industries Limited | 2-methyl-thieno-benzodiazepine |
PT582368E (pt) * | 1992-05-29 | 2001-05-31 | Lilly Co Eli | Derivados de tienobenzodiazepina para o tratamento de doencas de cns |
EP0620222A3 (en) * | 1993-04-14 | 1995-04-12 | Lilly Co Eli | Tetrahydro-beta-carbolines. |
HUT75522A (en) * | 1994-03-11 | 1997-05-28 | Lilly Co Eli | Indole-, pyrido-indole-, indolo-quinoline- and benzo-pyrido-indole-derivatives, method for treating 5ht2b receptor related conditions, pharmaceutical compositions containing them |
-
1994
- 1994-06-03 US US08/253,658 patent/US5457101A/en not_active Expired - Fee Related
-
1995
- 1995-05-29 ZA ZA954358A patent/ZA954358B/xx unknown
- 1995-05-29 NZ NZ272231A patent/NZ272231A/en unknown
- 1995-05-29 IL IL11391295A patent/IL113912A/xx not_active IP Right Cessation
- 1995-05-29 TW TW084105417A patent/TW372872B/zh active
- 1995-05-30 CA CA002150517A patent/CA2150517A1/en not_active Abandoned
- 1995-05-30 NO NO952130A patent/NO306977B1/no not_active IP Right Cessation
- 1995-05-31 AU AU20424/95A patent/AU684924B2/en not_active Ceased
- 1995-06-01 CN CN95106142A patent/CN1119101A/zh active Pending
- 1995-06-01 HU HU9501600A patent/HUT71598A/hu unknown
- 1995-06-01 KR KR1019950014504A patent/KR960000229A/ko not_active Application Discontinuation
- 1995-06-02 EP EP95303788A patent/EP0685233B1/en not_active Expired - Lifetime
- 1995-06-02 JP JP7136571A patent/JPH07330608A/ja not_active Withdrawn
- 1995-06-02 DE DE69528109T patent/DE69528109D1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1119101A (zh) | 1996-03-27 |
KR960000229A (ko) | 1996-01-25 |
US5457101A (en) | 1995-10-10 |
IL113912A0 (en) | 1995-08-31 |
DE69528109D1 (de) | 2002-10-17 |
NO952130L (no) | 1995-12-04 |
HU9501600D0 (en) | 1995-07-28 |
EP0685233A2 (en) | 1995-12-06 |
AU684924B2 (en) | 1998-01-08 |
TW372872B (en) | 1999-11-01 |
ZA954358B (en) | 1996-11-29 |
IL113912A (en) | 1999-04-11 |
NZ272231A (en) | 2001-05-25 |
JPH07330608A (ja) | 1995-12-19 |
CA2150517A1 (en) | 1995-12-04 |
EP0685233A3 (en) | 1996-04-03 |
EP0685233B1 (en) | 2002-09-11 |
NO306977B1 (no) | 2000-01-24 |
HUT71598A (en) | 1996-01-29 |
AU2042495A (en) | 1995-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO952130L (no) | Anvendelse av tieno(1,5)benzodiazepin for behandling av tilstander i mave/tarmkanalen | |
NO961006L (no) | Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene | |
NO974554L (no) | FremgangsmÕte for behandling av en underjordisk formasjon | |
NO991955L (no) | FremgangsmÕte for behandling av hydrokarboner | |
FI960548A0 (fi) | Foerfarande foer behandling av terminals foerbindelse med satellitkommunikationssystem | |
NO990225D0 (no) | Medikamenter for behandling av hyperfosfatemi | |
NO981800L (no) | FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan | |
NO944871D0 (no) | Fremgangsmåte for fremstilling av polydimetylsiloksaner | |
FI980387A0 (fi) | Foerfarande foer att foerhindra bildning av utfaellningar i svartlutsindunstare | |
NO972402D0 (no) | Fremgangsmåte for fremstilling av bærere | |
NO991734D0 (no) | Pyrazolinoner for behandling av potensforstyrrelser | |
NO20000933L (no) | Fremgangsmõte for fremstilling av polymer | |
NO973366D0 (no) | Fremgangsmåte for behandling av multippel sklerose | |
NO985535L (no) | FremgangsmÕte for fremstilling av 1,3-alkandioler | |
NO996432D0 (no) | Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider | |
NO982562D0 (no) | Sammensetning for behandling av smerte | |
NO991158D0 (no) | FremgangsmÕte for behandling av amyotrofisk lateralsklerose | |
NO993549L (no) | Imino-aza-antracyklinonderivater til behandling av amyloidosis | |
ID18263A (id) | Proses pembuatan polietilena tereftalat | |
NO986053D0 (no) | Antikonvulsive derivater for behandling av psoriasis | |
FI972694A0 (fi) | Uusi menetelmä sameridiinin valmistamiseksi | |
NO985558D0 (no) | Ny forbedret formulering for behandling av tromboembolisme | |
NO962812D0 (no) | Fremgangsmåte for behandling av nervebetennelse | |
NO994557D0 (no) | Fremgangsmaate for fremstilling av arylaminotriazolopyridiner | |
NO984190D0 (no) | Fremgangsmåte for behandling av insomnia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN NOVEMBER 2002 |